Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Chirch

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
AIDS Research and Treatment|May 10, 2021
Evaluation of Provider Screening Practices for Fracture Risk Assessment among Patients with HIV DiseaseFaryal Mirza, Sabina Zawadzka, Anne Abbate, et al.
Journal of the American Academy of Dermatology|June 21, 2014
Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis factor-alfa antagonistsLisa M Chirch, Philip R Cataline, Kevin D Dieckhaus, et al.
Journal of the American Academy of Dermatology|June 21, 2014
Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonistsLisa M Chirch, Philip R Cataline, Kevin D Dieckhaus, et al.
Ear, Nose, & Throat Journal|October 14, 2005
Tuberculous otitis media: report of 2 cases on Long Island, N.Y., and a review of all cases reported in the United States from 1990 through 2003Lisa M Chirch, Khalid Ahmad, Warren Spinner, et al.
AIDS Care|July 20, 2018
Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patientsDonald P Rice, Michelle A Ordoveza, Ann M Palmer, et al.
Medical Mycology Case Reports|March 9, 2026
Bury my axe in wounded knee: A case of native knee septic arthritis caused by multidrug resistant <i>Lomentospora</i> <i>prolificans</i>Weston Carpenter, Catherine Pulaski, Alexander Hahn, et al.
The Journal of Infectious Diseases|February 3, 2024
Analysis of the Infectious Diseases Fellowship Program Directors Postmatch 2023 SurveyHayden S Andrews, Lisa M Chirch, Vera P Luther, et al.
Open Forum Infectious Diseases|August 16, 2021
Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment ExperiencesDanica Rockney, Constance A Benson, Brian G Blackburn, et al.
Open Forum Infectious Diseases|March 4, 2024
High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training ProgramsVera P Luther, Molly L Paras, Sara Schultz, et al.
Open Forum Infectious Diseases|November 29, 2024
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive MessagingMolly L Paras, Lisa M Chirch, Mariam Aziz, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
AIDS Research and Treatment|May 10, 2021
Evaluation of Provider Screening Practices for Fracture Risk Assessment among Patients with HIV DiseaseFaryal Mirza, Sabina Zawadzka, Anne Abbate, et al.
Journal of the American Academy of Dermatology|June 21, 2014
Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis factor-alfa antagonistsLisa M Chirch, Philip R Cataline, Kevin D Dieckhaus, et al.
Journal of the American Academy of Dermatology|June 21, 2014
Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonistsLisa M Chirch, Philip R Cataline, Kevin D Dieckhaus, et al.
Ear, Nose, & Throat Journal|October 14, 2005
Tuberculous otitis media: report of 2 cases on Long Island, N.Y., and a review of all cases reported in the United States from 1990 through 2003Lisa M Chirch, Khalid Ahmad, Warren Spinner, et al.
AIDS Care|July 20, 2018
Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patientsDonald P Rice, Michelle A Ordoveza, Ann M Palmer, et al.
Medical Mycology Case Reports|March 9, 2026
Bury my axe in wounded knee: A case of native knee septic arthritis caused by multidrug resistant <i>Lomentospora</i> <i>prolificans</i>Weston Carpenter, Catherine Pulaski, Alexander Hahn, et al.
The Journal of Infectious Diseases|February 3, 2024
Analysis of the Infectious Diseases Fellowship Program Directors Postmatch 2023 SurveyHayden S Andrews, Lisa M Chirch, Vera P Luther, et al.
Open Forum Infectious Diseases|August 16, 2021
Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment ExperiencesDanica Rockney, Constance A Benson, Brian G Blackburn, et al.
Open Forum Infectious Diseases|March 4, 2024
High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training ProgramsVera P Luther, Molly L Paras, Sara Schultz, et al.
Open Forum Infectious Diseases|November 29, 2024
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive MessagingMolly L Paras, Lisa M Chirch, Mariam Aziz, et al.
Pageof 3